Protein Substitutes in PKU; Their Historical Evolution
Protein substitutes developed for phenylketonuria (PKU) are a synthetic source of protein commonly based on L-amino acids. They are essential in the treatment of phenylketonuria (PKU) and other amino acid disorders, allowing the antagonistic amino acid to be removed but with the safe provision of al...
Main Authors: | Anne Daly, Sharon Evans, Alex Pinto, Catherine Ashmore, Anita MacDonald |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-02-01
|
Series: | Nutrients |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6643/13/2/484 |
Similar Items
-
Growth and Body Composition in PKU Children—A Three-Year Prospective Study Comparing the Effects of L-Amino Acid to Glycomacropeptide Protein Substitutes
by: Anne Daly, et al.
Published: (2021-04-01) -
Preliminary Investigation to Review If a Glycomacropeptide Compared to L-Amino Acid Protein Substitute Alters the Pre- and Postprandial Amino Acid Profile in Children with Phenylketonuria
by: Anne Daly, et al.
Published: (2020-08-01) -
Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU
by: A. Daly, et al.
Published: (2019-02-01) -
Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
by: Anne Daly, et al.
Published: (2021-09-01) -
The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial
by: Anne Daly, et al.
Published: (2019-02-01)